Your browser doesn't support javascript.
loading
Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studies.
Felten, Renaud; Widawski, Laura; Spielmann, Lionel; Gaillez, Corine; Bao, Weibin; Gottenberg, Jacques-Eric; Duret, Pierre-Marie; Messer, Laurent.
Affiliation
  • Felten R; Department of Rheumatology, National Reference Centre for Rare East-South-West Autoimmune Systemic Diseases (RESO), Strasbourg University Hospitals, Strasbourg, Grand Est, France renaud.felten@chru-strasbourg.fr.
  • Widawski L; UPR 3572, Laboratory of Immunopathology and Therapeutic Chemistry, Institute of Molecular and Cellular Biology, Strasbourg, Alsace, France.
  • Spielmann L; Center of Clinical Investigation, Inserm 1434, Strasbourg University Hospitals, Strasbourg, Grand Est, France.
  • Gaillez C; Rheumatology Department, Civilian Hospitals Colmar, Colmar, Alsace, France.
  • Bao W; Rheumatology Department, Civilian Hospitals Colmar, Colmar, Alsace, France.
  • Gottenberg JE; Novartis Pharma AG, Basel, Basel-Stadt, Switzerland.
  • Duret PM; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Messer L; Department of Rheumatology, National Reference Centre for Rare East-South-West Autoimmune Systemic Diseases (RESO), Strasbourg University Hospitals, Strasbourg, Grand Est, France.
RMD Open ; 9(4)2023 11.
Article in En | MEDLINE | ID: mdl-37945285
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Psoriatic / Hyperuricemia Limits: Female / Humans / Male Language: En Journal: RMD Open Year: 2023 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Psoriatic / Hyperuricemia Limits: Female / Humans / Male Language: En Journal: RMD Open Year: 2023 Type: Article Affiliation country: France